Controlling the Redox Chemistry of Cobalt Radiopharmaceuticals.
Cancer
Radiopharmaceuticals
cobalt
radiochemistry
redox
Journal
Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Titre abrégé: Angew Chem Int Ed Engl
Pays: Germany
ID NLM: 0370543
Informations de publication
Date de publication:
23 Sep 2024
23 Sep 2024
Historique:
revised:
19
09
2024
received:
01
07
2024
accepted:
23
09
2024
medline:
23
9
2024
pubmed:
23
9
2024
entrez:
23
9
2024
Statut:
aheadofprint
Résumé
The elementally matched 55Co (t1/2 = 17.53 h, Iβ+ = 77%)/58mCo (t1/2 = 9.10 h, IC= 100%) radioisotope pair is of interest for development of paired diagnostic/therapeutic radiopharmaceuticals. Due to the accessibility of the Co2+/3+ redox couple, the redox state can be readily modulated. Here, we show that macroscopic and radiochemical redox reactions can be closely monitored and controlled using spectroscopic and radiochemical methods. We employ model systems to inform how to selectively synthesize thermodynamically favored coordination complexes. In addition to exogenous oxidants, our data indicates that 55Co-induced radiolysis of water efficiently and directly drives selective oxidation to the Co3+ species under no-carrier added (n.c.a.) conditions. Our synthetic strategies subsequently stabilize the respective 55Co2+ or 55Co3+ species for targeted Co-compounds' imaging in a mouse tumor model.
Identifiants
pubmed: 39312186
doi: 10.1002/anie.202412357
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e202412357Informations de copyright
© 2024 Wiley‐VCH GmbH.